Skip to main content

NK/T Lymphoma Diagnosis and Therapy

This invited review series for Journal of Hematology & Oncology provides the latest developments in NK/T-cell lymphoma research. 

Guest Editor: Prof. Yok-Lam Kwong (The University of Hong Kong, Hong Kong).

Articles published in the collection have already gone through the systematic peer review process of the journal.

New Content Item

  1. Extranodal NK/T cell lymphoma, nasal type (ENKTL) is an aggressive malignancy with a dismal prognosis. Although l-asparaginase-based chemotherapy has resulted in improved response rates, relapse occurs in up to 5...

    Authors: Sanjay de Mel, Susan Swee-Shan Hue, Anand D. Jeyasekharan, Wee-Joo Chng and Siok-Bian Ng
    Citation: Journal of Hematology & Oncology 2019 12:33
  2. Natural killer T cell lymphoma (NKTL) is an aggressive disease with very poor treatment outcomes in the advanced stages. With chemotherapy, initial response rates to treatment are high but responses are short ...

    Authors: Nagavalli Somasundaram, Jing Quan Lim, Choon Kiat Ong and Soon Thye Lim
    Citation: Journal of Hematology & Oncology 2019 12:28
  3. Natural-killer/T cell lymphoma (NKTCL) represents the most common subtype of extranodal lymphoma with aggressive clinical behavior. Prevalent in Asians and South Americans, the pathogenesis of NKTCL remains to...

    Authors: Jie Xiong and Wei-Li Zhao
    Citation: Journal of Hematology & Oncology 2018 11:134
  4. Natural killer/T-cell lymphoma (NKTCL) is a rare subtype of non-Hodgkin lymphoma that is associated with a poor outcome. Currently, the treatment needs of NKTCL remain unmet, and efforts to further improve tre...

    Authors: Xin Li, Yasong Cheng, Mingzhi Zhang, Jiaqin Yan, Ling Li, Xiaorui Fu, Xudong Zhang, Yu Chang, Zhenchang Sun, Hui Yu, Lei Zhang, Xinhua Wang, Jingjing Wu, Zhaoming Li, Feifei Nan, Li Tian…
    Citation: Journal of Hematology & Oncology 2018 11:15